| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2035818 | Cell | 2012 | 4 Pages |
Abstract
By targeting surface antigens expressed on tumor cells, monoclonal antibodies have demonstrated efficacy as cancer therapeutics. Recent successful antibody-based strategies have focused on enhancing antitumor immune responses by targeting immune cells, irrespective of tumor antigens. We discuss these innovative strategies and propose how they will impact the future of antibody-based cancer therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Louis M. Weiner, Joseph C. Murray, Casey W. Shuptrine,